----

----

| þ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|--------|--------------------------------------------------------------------------------------|

| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---|------------------------------------------------------------------------------------------|

| CEL-SCI CORPORATION                                    |
|--------------------------------------------------------|
| (Exact name of registrant as specified in its charter) |

| COLORADO                                                             |   | 84-0916344                           |
|----------------------------------------------------------------------|--------|--------------------------------------|
| (State or other jurisdiction of incorporation or organization)  |   | (I.R.S. Employer Identification No.) |

| 8229 Boone Blvd., Suite 802Vienna, Virginia |   | 22182      |
|---------------------------------------------|--------|------------|
| (Address of principal executive offices)    |   | (Zip Code) |

| Common Stock, $.01 par value Series S Warrants |
|------------------------------------------------|
| (Title of Class)                               |

| Large accelerated filer                             | o      | Accelerated filer    | þ |
|-----------------------------------------------------|--------|---------------------------|--------|
| Non-accelerated filer                               | o      | Smaller reporting company | o      |
| (Do not check if a smaller reporting company)  |   |                      |   |

----

----

| ●   | Revise Item 15; and |
|---------------------|---------------------|

| ●   | file Exhibit 4(f) which was previously incorporated by reference. |
|---------------------|-------------------------------------------------------------------|

----

| Exhibits |   |                                          |   |                                                                                                                                                                                                 |
|----------|--------|-----------------------------------------------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|     |   |                                          |   |                                                                                                                                                                                                 |
| 3(a)     |   | Articles of Incorporation                     |   | Incorporated by reference to Exhibit 3(a) of CEL-SCI's combined Registration Statement on Form S-1 and Post-Effective Amendment ("Registration Statement"), Registration Nos. 2-85547-D and 33-7531. |
|     |   |                                          |   |                                                                                                                                                                                                 |
| 3(b)     |   | Amended Articles                              |   | Incorporated by reference to Exhibit 3(a) of CEL-SCI's Registration Statement on Form S-1, Registration Nos. 2-85547-D and 33-7531.                                                                  |
|     |   |                                          |   |                                                                                                                                                                                                 |
| 3(c)     |   | Amended Articles (Name change only)           |   | Filed as Exhibit 3(c) to CEL-SCI's Registration Statement on Form S-1 Registration Statement (No. 33-34878).                                                                                         |
|     |   |                                          |   |                                                                                                                                                                                                 |
| 3(d)     |   | Bylaws                                        |   | Incorporated by reference to Exhibit 3(b) of CEL-SCI's Registration Statement on Form S-1, Registration Nos. 2-85547-D and 33-7531.                                                                  |
|     |   |                                          |   |                                                                                                                                                                                                 |
| 3(e)     |   | Amended Bylaws                                |   | Incorporated by reference to Exhibit 3(ii) of CEL-SCI’s report on Form 8-K dated March 16, 2015.                                                                                               |
|     |   |                                          |   |                                                                                                                                                                                                 |
| 4        |   | Shareholders Rights Agreement                 |   | Incorporated by reference to Exhibit 4 of CEL-SCI’S report on Form 8-K dated November 7, 2007.                                                                                                 |
|     |   |                                          |   |                                                                                                                                                                                                 |
| 4(b)     |   | Incentive Stock Option Plan                   |   | Incorporated by reference to Exhibit 4 (b) filed on September 25, 2012 with the Company’s registration statement on Form S¬8 (File number 333-184092.                                     |
|     |   |                                          |   |                                                                                                                                                                                                 |
| 4(c)     |   | Non-Qualified Stock Option Plan               |   | Incorporated by reference to Exhibit 4 (b) filed on August 19, 2014 with the Company’s registration statement on Form S¬8 (File number 333-198244).                                       |
|     |   |                                          |   |                                                                                                                                                                                                 |
| 4(d)     |   | Stock Bonus Plan                              |   | Incorporated by reference to Exhibit 4 (d) filed on September 25, 2012 with the Company’s registration statement on Form S¬8 (File number 333-184092.                                     |
|     |   |                                          |   |                                                                                                                                                                                                 |
| 4(e)     |   | Stock Compensation Plan                       |   | Incorporated by reference to Exhibit 4 (e) filed on September 25, 2012 with the Company’s registration statement on Form S¬8 (File number 333-184092.                                     |
|     |   |                                          |   |                                                                                                                                                                                                 |
| 4(f)     |   | 2014 Incentive Stock Bonus Plan               |   | Filed with this Amendment No. 2 to the Company’s annual report on Form 10-K for the year ended September 30, 2014.                                                                             |
|     |   |                                          |   |                                                                                                                                                                                                 |
| 10(d)    |   | Employment Agreement with Maximilian de Clara |   | Incorporated by reference to Exhibit 10(d) of CEL-SCI’s report on Form 8-K (dated April 21, 2005) and Exhibit 10(d) to CEL-SCI’s report on Form 8-K dated September 8, 2006.             |

----

|   |   |                                                                                                                                                                                                                                                      |   |                                                                                                                                                                                      |
|--------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 10(f)  |   | Securities Purchase Agreement (together with schedule required by Instruction 2 to Item 601 of Regulation S-K) pertaining to Series K notes and warrants, together with the exhibits to the Securities Purchase Agreement                                 |   | Incorporated by reference to Exhibit 10 to CEL-SCI’s report on Form 8-K dated August 4, 2006.                                                                                       |
|   |   |                                                                                                                                                                                                                                                      |   |                                                                                                                                                                                      |
| 10(g)  |   | Subscription Agreement (together with Schedule required by Instruction 2 to Item 601 of Regulation S-K) pertaining to April 2007 sale of 20,000,000 shares of CEL-SCI’s common stock, 10,000,000 Series L warrants and 10,000,000 Series M Warrants |   | Incorporated by reference to Exhibit 10 of CEL-SCI’s report on Form 8-K dated April 18, 2007                                                                                        |
|   |   |                                                                                                                                                                                                                                                      |   |                                                                                                                                                                                      |
| 10(h)  |   | Warrant Adjustment Agreement with Laksya Ventures                                                                                                                                                                                                         |   | Incorporated by reference to Exhibit 10(i) of CEL-SCI’s report on Form 8-K dated August 3, 2010                                                                                     |
|   |   |                                                                                                                                                                                                                                                      |   |                                                                                                                                                                                      |
| 10(i)  |   | Employment Agreement with Patricia Prichep (2013-2016)                                                                                                                                                                                                    |   | Incorporated by reference to Exhibit 10(j) of CEL-SCI’s report on Form 8-K dated August 30, 2013                                                                                    |
|   |   |                                                                                                                                                                                                                                                      |   |                                                                                                                                                                                      |
| 10(j)  |   | Employment Agreement with Eyal Taylor (2013-2016)                                                                                                                                                                                                         |   | Incorporated by reference to Exhibit 10(k) of CEL-SCI’s report on Form 8-K dated August 30, 2013.                                                                                   |
|   |   |                                                                                                                                                                                                                                                      |   |                                                                                                                                                                                      |
| 10(k)  |   | Amendment to Employment Agreement with Maximilian de Clara                                                                                                                                                                                                |   | Incorporated by reference to Exhibit 10(l) of CEL-SCI’s report on Form 8-K dated August 30, 2010 and Exhibit 10(l) of CEL-SCI’s report on Form 8-K dated August 30, 2013.     |
|   |   |                                                                                                                                                                                                                                                      |   |                                                                                                                                                                                      |
| 10(l)  |   | First Amendment to Development Supply and Distribution Agreement with Orient Europharma.                                                                                                                                                                  |   | Incorporated by reference to Exhibit 10(m) filed with CEL-SCI’s 10-K report for the year ended September 30, 2010.                                                                  |
|   |   |                                                                                                                                                                                                                                                      |   |                                                                                                                                                                                      |
| 10(m)  |   | Exclusive License and Distribution Agreement with Teva Pharmaceutical Industries Ltd.                                                                                                                                                                |   | Incorporated by reference to Exhibit 10(n) filed with CEL-SCI’s 10-K report for the year ended September 30, 2010.                                                                  |
|   |   |                                                                                                                                                                                                                                                      |   |                                                                                                                                                                                      |
| 10(n)  |   | Lease Agreement                                                                                                                                                                                                                                           |   | Incorporated by reference to Exhibit 10(o) filed with CEL-SCI’s 10-K report for the year ended September 30, 2010.                                                                  |
|   |   |                                                                                                                                                                                                                                                      |   |                                                                                                                                                                                      |
| 10(o)  |   | Promissory Note with Maximilian de Clara, together with Amendments 1 and 2                                                                                                                                                                                |   | Incorporated by reference to Exhibit 10(p)  filed with CEL-SCI’s 10-K report for the year ended September 30, 2010.                                                            |
|   |   |                                                                                                                                                                                                                                                      |   |                                                                                                                                                                                      |
| 10(p)  |   | Licensing Agreement with Byron Biopharma                                                                                                                                                                                                                  |   | Incorporated by reference to Exhibit 10(i) of CEL-SCI’s report on Form 8-K dated March 27, 2009                                                                                |
|   |   |                                                                                                                                                                                                                                                      |   |                                                                                                                                                                                      |
| 10(q)  |   | At Market Issuance Sales Agreement with McNicoll, Lewis & Vlak LLC                                                                                                                                                                                    |   | Incorporated by reference to Exhibit 10(r) filed with CEL-SCI’s 10-K report for the year ended September 30, 2010                                                                   |
|   |   |                                                                                                                                                                                                                                                      |   |                                                                                                                                                                                      |
| 10(z)  |   | Development, Supply and Distribution Agreement with Orient Europharma                                                                                                                                                                                     |   | Incorporated by reference to Exhibit 10(z) filed with CEL-SCI’s report on Form 10-K for the year ended September 30, 2003.                                                     |
|   |   |                                                                                                                                                                                                                                                      |   |                                                                                                                                                                                      |
| 10(za) |   | Employment Agreement with Geert Kersten.  Amendment to Employment Agreement                                                                                                                                                                     |   | Incorporated by reference to Exhibit 10(za) to CEL-SCI’s report on Form 8-K dated September 1, 2011 and Exhibit 10(za) of CEL-SCI’s report on Form 8-K dated August 30, 2013. |
|   |   |                                                                                                                                                                                                                                                      |   |                                                                                                                                                                                      |
| 10(aa) |   | Securities Purchase Agreement and form of the Series F warrants, which is and exhibit to the Securities Purchase Agreement                                                                                                                                |   | Incorporated by reference to Exhibit 10(aa) of CEL-SCI’s report on Form 8-K dated October 3, 2011.                                                                                  |

----

|   |   |                      |   |                                                                                                     |
|--------|--------|---------------------------|--------|----------------------------------------------------------------------------------------------------------|
| 10(bb) |   | Placement Agent Agreement |   | Incorporated by reference to Exhibit 10(bb) of CEL-SCI’s report on Form 8-K dated October 3, 2011. |

| 10(cc)  |   | Securities  Purchase Agreement,  together with  the form of the Series H warrant, which is an exhibit to the securities Purchase Agreement                                        |   | Incorporated by reference to Exhibit 10(cc) of CEL-SCI’s report on Form 8-K dated January 25, 2012.             |
|---------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|-----------------------------------------------------------------------------------------------------------------------|
|    |   |                                                                                                                                                                                                            |   |                                                                                                                  |
| 10(dd)  |   | Placement Agent Agreement                                                                                                                                                                                       |   | Incorporated by reference to Exhibit 10(dd)  of CEL-SCI’s report on Form 8-K dated January 25, 2012.  |
|    |   |                                                                                                                                                                                                            |   |                                                                                                                  |
| 10(ee)  |   | Warrant Amendment Agreement, together with the form of the Series P warrant, which is an exhibit to the Warrant Amendment Agreement                                                                             |   | Incorporated by reference to Exhibit 10(ee)  of CEL-SCI’s report on Form 8-K dated February 10, 2012. |
|    |   |                                                                                                                                                                                                            |   |                                                                                                                  |
| 10(ff)  |   | Placement Agent Agreement                                                                                                                                                                                       |   | Incorporated by reference to Exhibit 10(ff)  of CEL-SCI’s report on Form 8-K dated February 10, 2012. |
|    |   |                                                                                                                                                                                                            |   |                                                                                                                  |
| 10(gg)  |   | Securities  Purchase  Agreement  and the form of the  Series Q   warrant,  which is an  exhibit to the Securities Purchase Agreement |   | Incorporated by reference to Exhibit 10(gg)  of CEL-SCI’s report on Form 8-K dated June 18, 2012.     |
|    |   |                                                                                                                                                                                                            |   |                                                                                                                  |
| 10(hh)  |   | Placement Agent Agreement                                                                                                                                                                                       |   | Incorporated by reference to Exhibit 10(hh)  of CEL-SCI’s report on Form 8-K dated June 18, 2012.     |
|    |   |                                                                                                                                                                                                            |   |                                                                                                                  |
| 10 (ii) |   | Securities  Purchase  Agreement  and the form of the  Series R   warrant,  which is an  exhibit to the Securities Purchase Agreement |   | Incorporated by reference to Exhibit 10(ii)  of CEL-SCI’s report on Form 8-K dated December 5, 2012.  |
|    |   |                                                                                                                                                                                                            |   |                                                                                                                  |
| 10 (jj) |   | Placement Agent Agreement                                                                                                                                                                                       |   | Incorporated by reference to Exhibit 10(jj)  of CEL-SCI’s report on Form 8-K dated December 5, 2012.  |
|    |   |                                                                                                                                                                                                            |   |                                                                                                                  |
| 10 (nn) |   | Underwriting Agreement, together with the form of Series S warrant which is an exhibit to the underwriting agreement                                                                                            |   | Incorporated by reference to Exhibit 1.1 of CEL-SCI’s report on Form 8-K dated October 8, 2013.            |
|    |   |                                                                                                                                                                                                            |   |                                                                                                                  |
| 10 (oo) |   | Underwriting Agreement, together with the form of Series S warrant which is an exhibit to the underwriting agreement                                                                                            |   | Incorporated by reference to Exhibit 1.1 of CEL-SCI’s report on Form 8-K dated December 19, 2013.               |
|    |   |                                                                                                                                                                                                            |   |                                                                                                                  |
| 10 (pp) |   | Underwriting Agreement, together with the form of Series T warrant which is an exhibit to the warrant agent agreement                                                                                           |   | Incorporated by reference to Exhibit 1.1 of CEL-SCI’s report on Form 8-K dated April 15, 2014.             |
|    |   |                                                                                                                                                                                                            |   |                                                                                                                  |
| 10 (qq) |   | Underwriting Agreement, together with the form of Series S warrant which is an exhibit to the warrant agent agreement                                                                                           |   | Incorporated by reference to Exhibit 1.1 of CEL-SCI’s report on Form 8-K dated October 23, 2014.                |
|    |   |                                                                                                                                                                                                            |   |                                                                                                                  |
| 10 (rr) |   | Assignment and Assumption Agreement with Teva Pharmaceutical Industries, Ltd. and GCP Clinical Studies, Ltd.                                                                                                    |   | (1)                                                                                                                   |
|    |   |                                                                                                                                                                                                            |   |                                                                                                                  |
| 10 (ss) |   | Service Agreement with GCP Clinical Studies, Ltd., together with Amendment 1 thereto*                                                                                                                           |   | (1)                                                                                                                   |
|    |   |                                                                                                                                                                                                            |   |                                                                                                                  |
| 10 (tt) |   | Joinder Agreement with PLIVA Hrvatska d.o.o.                                                                                                                                                                    |   | (1)                                                                                                                   |
|    |   |                                                                                                                                                                                                            |   |                                                                                                                  |
| 10 (uu) |   | Master Service Agreement with Ergomed Clinical Research, Ltd.,  and Clinical Trial Orders thereunder                                                                                                  |   | (1)                                                                                                                   |

----

| 10 (vv)  |   | Co-Development and Revenue Sharing Agreement with Ergomed Clinical Research Ltd., dated April 19, 2013, as amended                                                                                   |   | (1)    |
|----------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|
|     |   |                                                                                                                                                                                                 |   |   |
| 10 (ww)  |   | Co-Development and Revenue Sharing Agreement II:  Cervical Intraepithelial Neoplasia in HIV/HPV co-infected women, with Ergomed Clinical Research Ltd., dated October 10, 2013, as amended |   | (1)    |
|     |   |                                                                                                                                                                                                 |   |   |
| 10 (xx)  |   | Co-Development and Revenue Sharing Agreement III: Anal warts and anal intraepithelial neoplasia in HIV/HPV co-infected patients, with Ergomed Clinical Research Ltd., dated October 24, 2013         |   | (1)    |
|     |   |                                                                                                                                                                                                 |   |   |
| 10 (yy)  |   | Master Services Agreement with Aptiv Solutions, Inc.                                                                                                                                                 |   | (1)    |
|     |   |                                                                                                                                                                                                 |   |   |
| 10 (zz)  |   | Project Agreement Number 1 with Aptiv Solutions, Inc. together with Amendments 1 and 2 thereto*                                                                                                      |   | (1)    |
|     |   |                                                                                                                                                                                                 |   |   |
| 10 (aaa) |   | Second Amendment to Development Supply and Distribution Agreement with Orient Europharma                                                                                                             |   | (1)    |
|     |   |                                                                                                                                                                                                 |   |   |
| 10 (bbb) |   | Amended and Restated Promissory Note with Maximilian de Clara                                                                                                                                        |   | (1)    |
|     |   |                                                                                                                                                                                                 |   |   |
| 31       |   | Rule 13a-14(a) Certifications                                                                                                                                                                        |   |   |
|     |   |                                                                                                                                                                                                 |   |   |
| 32       |   | Section 1350 Certifications                                                                                                                                                                          |   |   |

| 1. | Filed on April 17, 2015 with the Company’s first amendment to its 10-K report for the year ended September 30, 2014. |
|----|----------------------------------------------------------------------------------------------------------------------------|

----

|   | CEL-SCI CORPORATION |                           |
|--------|---------------------|--------------------------------|
|   |                |                           |   |
|   | By:                 | /s/ Maximilian de Clara   |   |
|   |                | Maximilian de Clara, President |   |
|   |                |                           |   |
|   |                |                           |   |

| Signature                  |   | Title                                                                             |   | Date                |
|----------------------------|--------|-----------------------------------------------------------------------------------|--------|---------------------|
|                       |   |                                                                              |   |                |
| /s/ Maximilian de Clara    |   | Director                                                                          |   | July  17, 2015 |
| Maximilian de Clara        |   |                                                                              |   |                |
|                       |   |                                                                              |   |                |
| /s/ Geert R. Kersten       |   | Chief Executive, Principal Accounting, Principal Financial Officer and a Director |   | July 17, 2015       |
| Geert R. Kersten           |   |                                                                              |   |                |
|                       |   |                                                                              |   |                |
| /s/ Alexander G. Esterhazy |   | Director                                                                          |   | July 17, 2015       |
| Alexander G. Esterhazy     |   |                                                                              |   |                |
|                       |   |                                                                              |   |                |
| /s/ Dr. Peter R. Young     |   | Director                                                                          |   | July 17, 2015       |
| Dr. Peter R. Young         |   |                                                                              |   |                |

----